首页> 外文期刊>International immunopharmacology >WITHDRAWN: Dual targeting of glioma U251 cells and neovasculature with a nanoparticle encoding vasohibin and RGD peptides prevents tumor angiogenesis and inhibits tumor growth.
【24h】

WITHDRAWN: Dual targeting of glioma U251 cells and neovasculature with a nanoparticle encoding vasohibin and RGD peptides prevents tumor angiogenesis and inhibits tumor growth.

机译:撤回:用编码血管抑制素和RGD肽的纳米粒子对神经胶质瘤U251细胞和新脉管系统进行双重靶向可防止肿瘤血管生成并抑制肿瘤生长。

获取原文
获取原文并翻译 | 示例
           

摘要

This article has been withdrawn at the request of the author(s) and editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
机译:本文已应作者和编辑的要求撤回。对于由此给您带来的任何不便,出版商深表歉意。完整的Elsevier物品提取政策可在http://www.elsevier.com/locate/withdrawalpolicy中找到。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号